Article
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis.
Cancer treatment reviews - 1 Nov 2022
Corrie Pippa, Meyer Nicolas, Berardi Rossana, Guidoboni Massimo, Schlueter Maximilian, Kolovos Spyros, Macabeo Bérengère, Trouiller Jean-Baptiste, Laramée Philippe
Abstract excerpt
BACKGROUND: The objective of this study was to estimate the relative efficacy and safety of targeted therapies for the treatment of metastatic melanoma using a network meta-analysis (NMA). METHODS: A systematic literature review (SLR) identified studies in Medline, Embase and Cochrane published until November 2020. Screening used prespecified eligibility criteria. Following a transitivity assessment across...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.